Miconazole Vaginal

Contraindicated

Miconazole Vaginal Deuruxolitinib Increased deuruxolitinib exposure and an increased risk of deuruxolitinib-related adverse effects such as thrombosis Details Miconazole Vaginal Pimozide An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details

Major

Miconazole Vaginal Amiodarone Nexterone Increased amiodarone exposure Details Miconazole Vaginal Carvedilol Coreg Increased carvedilol concentrations and an increased risk of bradycardia or heart block Details Miconazole Vaginal Celecoxib Celebrex Increased celecoxib exposure Details Miconazole Vaginal Cilostazol Pletal® Increased cilostazol exposure Details Miconazole Vaginal Domperidone Increased domperidone exposure and an increased risk of QT interval prolongation Details Miconazole Vaginal Erdafitinib Balversa Increased erdafitinib exposure Details Miconazole Vaginal Escitalopram Lexapro Increased risk of serotonin syndrome (hypertension, tachycardia, hyperthermia, myoclonus, mental status changes) Details Miconazole Vaginal Etonogestrel Nexplanon Increased etonogestrel exposure Details Miconazole Vaginal Fosphenytoin Cerebyx Increased phenytoin or fosphenytoin (prodrug of phenytoin) exposure and an increased risk of phenytoin or fosphenytoin toxicity (a... Details Miconazole Vaginal Glimepiride Amaryl Severe hypoglycemia Details Miconazole Vaginal Ifosfamide Ifex Decreased ifosfamide effectiveness Details Miconazole Vaginal Meloxicam Alloxate Increased meloxicam exposure and reduced meloxicam metabolic clearance Details Miconazole Vaginal Methadone Diskets Increased methadone exposure and an increased risk of opioid adverse effects Details Miconazole Vaginal Naloxegol Movantik Increased naloxegol exposure Details Miconazole Vaginal Olaparib Lynparza Increased olaparib exposure Details Miconazole Vaginal Phenobarbital Fidoquel Increased PHENobarbital exposure and an increased risk of PHENobarbital-related adverse effects Details Miconazole Vaginal Phenytoin Dilantin Increased phenytoin or fosphenytoin (prodrug of phenytoin) exposure and an increased risk of phenytoin or fosphenytoin toxicity (a... Details Miconazole Vaginal Piperaquine Increased exposure of piperaquine Details Miconazole Vaginal Primidone Mysoline Increased PHENobarbital exposure and an increased risk of PHENobarbital-related adverse effects Details Miconazole Vaginal Simeprevir Olysio® Increased simeprevir exposure Details Miconazole Vaginal Voriconazole Vfend Increased voriconazole exposure Details Miconazole Vaginal Warfarin Coumadin Increased warfarin exposure, an increased INR and an increased risk of bleeding Details

Moderate

Miconazole Vaginal Aceclofenac Increased exposure of diclofenac Details Miconazole Vaginal Acenocoumarol An increased risk of bleeding Details Miconazole Vaginal Anisindione Increased risk of bleeding Details Miconazole Vaginal Cyclosporine Atopica An increased risk of cycloSPORINE toxicity (renal dysfunction, cholestasis, paresthesias) Details Miconazole Vaginal Diclofenac Aleve Arthritis Pain Increased exposure of diclofenac Details Miconazole Vaginal Dicumarol An increased risk of bleeding Details Miconazole Vaginal Ethinyl Estradiol Increased exposure to ethinyl estradiol Details Miconazole Vaginal Nateglinide Starlix® Increased risk of hypoglycemia Details Miconazole Vaginal Oxybutynin Ditropan Increased oxybutynin exposure or plasma concentrations Details Miconazole Vaginal Phenindione An increased risk of bleeding Details Miconazole Vaginal Phenprocoumon Increased risk of bleeding Details Miconazole Vaginal Tolterodine Detrol Enhanced tolterodine bioavailability in individuals with deficient cytochrome P450 2D6 activity Details Miconazole Vaginal Trimetrexate Increased trimetrexate toxicity (bone marrow suppression, renal & hepatic dysfunction, and gastrointestinal ulceration) Details